BioWorld. Link to homepage.
BioWorld
BioWorld MedTech
BioWorld Asia
BioWorld Science
Data Snapshots
BioWorld
BioWorld MedTech
Infographics: Dynamic digital data analysis
Special reports
Aging
Alzheimer's disease
Artificial intelligence
Biosimilars
China CAR T
Coronavirus
Infographics: Dynamic digital data analysis
Israel
IVDs on the rise
Radiopharmaceuticals
Rise of obesity
Top Biopharma Trends of 2023
Top Med-tech Trends of 2023
Top Preclinical Trends of 2023
Premium reports
BioWorld Financings Reports
Disease Incidence & Prevalence Summaries
BioWorld. Link to homepage.
sign in
Sign Out
My Account
Subscribe
BioWorld - Thursday, April 25, 2024
Home
»
Newsletters
» BioWorld Science
BioWorld Science
Sep. 7, 2015
View Archived Issues
Modified cobratoxin RPI-78M granted U.S. orphan status for pediatric multiple sclerosis
Read More
Ex scientia delivers first compound in Sumitomo Dainippon collaboration
Read More
Incyte and Jiangsu Hengrui Medicine sign global license agreement for SHR-120
Read More
Novimmune and Baxalta form collaboration to discover bispecific antibodies
Read More
Redx and Horizon Discovery establish cancer research collaboration
Read More
Department of Defense awards Cleveland BioLabs contract for development of entolimod
Read More
Prostate tissue accumulation inconsistent with absorption-enhanced formulation of DIM
Read More
Dose-response effects described for encenicline in schizophrenia
Read More
Patupilone active against brain metastases from non-small cell lung cancer
Read More
Cellsight Technologies PET tracer [18F]F-AraG first-in-human results are positive
Read More
FORUM Pharmaceuticals describes PDE9A inhibitors that may improve cognition
Read More
Daiichi Sankyo discloses RuvB-like 1/RuvB-like 2 complex ATPase inhibitors
Read More
Bionomics presents new VEGFR-3/FAK inhibitors
Read More
Novartis' Farydak receives E.U. approval for multiple myeloma
Read More
Achillion discovers complement factor D inhibitors
Read More
Boehringer Ingelheim discloses neutrophil elastase inhibitors
Read More
Bristol-Myers Squibb introduces HIV integrase inhibitors
Read More
FDA extends PDUFA date for Kanuma
Read More
Relief Therapeutics licenses atexakin alfa rights from Merck Serono
Read More
FDA grants priority review to daratumumab BLA for multiple myeloma
Read More
Allergan to acquire ocular device company AqueSys
Read More
FDA approves Xuriden for hereditary orotic aciduria
Read More
Terumo's autologous skeletal myoblast sheets approved in Japan for heart failure
Read More
Audentes Therapeutics acquires Cardiogen Sciences
Read More
Glenmark completes phase I studies for GBR-830
Read More
Exploratory trial of SAGE-547 in essential tremor shows significant reduction in tremor
Read More